Joana Goncalves, Chief Medical Officer at Oruka Therapeutics, Inc. (ORKA), sold 11,867 shares at $29.62 ($364K) on 2025-12-19, disclosed to the SEC on 2025-12-19.
Scheduled sale ($364k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.53 | 641 | $18K | 5.0% |
| 2 | $29.62 | 1,787 | $53K | 14.5% |
| 3 | $29.62 | 1,787 | $53K | 14.5% |
| 4 | $30.70 | 1,492 | $46K | 12.6% |
| 5 | $31.58 | 3,080 | $97K | 26.7% |
| 6 | $31.58 | 3,080 |
| $97K |
| 26.7% |
| Total | $30.71 avg | 11,867 | $364K | 100% |
| Filing → |
| ORKA | SELL | 2026-07-15 | $604K | — | Filing → |
| ORKA | SELL | 2026-06-15 | $551K | — | Filing → |
| ORKA | SELL | 2026-05-15 | $433K | — | Filing → |